Microcrystalline Hydroxyapatite (MCHA)
Ground bone-matrix calcium that also contains collagen and trace minerals. Older reviews are enthusiastic, but the best controlled comparison found it equivalent to — not better than — ordinary calcium salts.
Evidence last reviewed: August 2026
What the science says
- Equivalent, not superior, to plain calcium salts Moderate evidence
A randomized trial in 100 postmenopausal women compared two MCHA preparations with calcium citrate/carbonate and placebo. MCHA raised ionised calcium less (but raised phosphate more) and produced comparable reductions in bone turnover markers at 3 months — equivalence, not an advantage.
- Favourable reviews rest on weak studies Limited evidence
A narrative review of the ossein-hydroxyapatite complex concluded it preserves bone mass better than calcium carbonate, but it draws on older, small and largely industry-linked trials using bone-density surrogates rather than fractures.
- No fracture data Strong evidence
No trial has tested MCHA against fractures. The wider evidence base — a 2026 review of 69 trials in 153,902 people — shows calcium supplementation in general has little to no effect on fracture or fall risk.
Dosage & safety
Scientific references
- Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: a randomised controlled trial in postmenopausal women
- Use of ossein-hydroxyapatite complex in the prevention of bone loss: a review
- Calcium, vitamin D, or combined supplementation to prevent fractures and falls: systematic review and meta-analysis
Where to buy
Referral link — this site may earn a commission on purchases.
Related in Vitamins & minerals
- Vitamin A (Retinol) Moderate evidence
- Vitamin B1 (Thiamine) Moderate evidence
- Vitamin B5 (Pantothenic Acid) Limited evidence
- Vitamin B6 (Pyridoxine) Moderate evidence
- Vitamin K1 Limited evidence
- Calcium Moderate evidence